Institutions / General Atlantic, L.P. / Activity
Activity — General Atlantic, L.P.
6 moves.
| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Q1 2026 as of | Trim | Nurix Therapeutics, Inc. Common stock | $-12.33M | -795K -16.24% | 4,101,865 2.96% of portfolio | medium |
| Q1 2026 as of | Trim | G98239109 Common stock | $-40.61M | -2.1M -9.40% | 20,566,133 18.23% of portfolio | medium |
| Q1 2026 as of | Add | Alkami Technology, Inc. Common stock | $52.43M | +3.3M +27.90% | 15,337,495 11.19% of portfolio | high |
| Q1 2026 as of | Trim | 152309100 Common stock | $-189.18M | -4.8M -77.85% | 1,354,830 2.50% of portfolio | high |
| Q1 2026 as of | Trim | Revolution Medicines, Inc. Common stock | $-204.72M | -2.1M -74.84% | 707,791 3.20% of portfolio | high |
| Q1 2026 as of | Exit | Alignment Healthcare, Inc. Common stock | $-260.06M | -13.2M -100.00% | 0 | high |